CORDIS
EU research results

CORDIS

English EN
Molecular phenotyping to accelerate genomic epidemiology

Molecular phenotyping to accelerate genomic epidemiology

Objective

Epidemiologists, clinical trialists and experimental scientists are confronted with a wealth of potential opportunities for molecular phenotyping large numbers of biological samples obtained from cohorts, patients or animal models. The challenge now is to ensure that these tools are developed to permit high-throughput analyses of significant numbers of samples, cohort protocols are in place for sample collection and storage, and that systems are in place to capture, warehouse and analyse the range of biolog ical data that will emerge from these studies. This consortium will bring some of these tools into practice during the course of the next four years so that they can be used to identify biomarkers that predict disease, determine risk and relate to disease activity or response to therapy. The programme is divided into three parts: 1. The evaluation of sample collection and storage methodology to optimally sample variation and disease analyte stability. 2. The development of tools for molecular phenotyping at epidemiologic scale including measuring small molecules (metabonomics), mRNA in white blood cells (transcription profiling, protein and peptide analysis using mass spectrometry methodology, affinity arrays and tissue arrays, DNA methdylation patterns and genetics. 3. The development of bioinformatic tools for data warehousing, data interrogation and statistical analysis in large sample sets. 4. The consortium will adopt two separate approaches (i) genome wide, systematic methodology (metabonomics, ms based metanomics) and (ii) limited analysis using sets of candidate biomarkers (transcipt profiling, methylation, affinity arrays, tissue arrays) Collectively, these programmes bring together the necessary skills and tools to allow moleculear phenotyping to be realistically applied, informing our study of common disease and its treatment.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

THE CHANCELLORS, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

Address

University Offices, Wellington Square
Oxford

United Kingdom

Administrative Contact

John BELL (Professor)

Participants (20)

Sort alphabetically

Expand all

AFFIBODY AB

Sweden

BIOVISION AG

Germany

CHARLES UNIVERSITY, THIRD FACULTY OF MEDICINE

Czechia

COMMISSARIAT A L'ENERGIE ATOMIQUE

France

CONSORTIUM NATIONAL DE RECHERCHE EN GENOMIQUE

France

DIGILAB BIOVISION GMBH

Germany

EPIGENOMICS. AG

Germany

EUROPEAN MOLECULAR BIOLOGY LABORATORY.

Germany

F. HOFFMANN LA ROCHE AG

Switzerland

GUYS AND ST THOMAS HOSPITAL NHS TRUST

United Kingdom

GYROS AB

Sweden

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

United Kingdom

INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE

France

INSTITUTE OF MATHEMATICS AND COMPUTER SCIENCE, UNIVERSITY OF LATVIA

Latvia

KING'S COLLEGE LONDON

United Kingdom

KUNGLIGA TEKNISKA HÖGSKOLAN

Sweden

NOVO NORDISK A/S

Denmark

OXFORD GENE TECHNOLOGY (OPERATIONS) LTD

United Kingdom

UNIVERSITY OF PAVIA (UNIVERSITA DI PAVIA)

Italy

UPPSALA UNIVERSITY

Sweden

Project information

Grant agreement ID: 512066

  • Start date

    1 October 2004

  • End date

    31 March 2009

Funded under:

FP6-LIFESCIHEALTH

  • Overall budget:

    € 17 456 550

  • EU contribution

    € 12 000 000

Coordinated by:

THE CHANCELLORS, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom